Ventripoint Diagnostics Stock Market Value
| VPTDF Stock | USD 0.09 0.01 14.20% |
| Symbol | VentriPoint |
VentriPoint Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VentriPoint Diagnostics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VentriPoint Diagnostics.
| 09/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in VentriPoint Diagnostics on September 23, 2024 and sell it all today you would earn a total of 0.00 from holding VentriPoint Diagnostics or generate 0.0% return on investment in VentriPoint Diagnostics over 60 days. VentriPoint Diagnostics is related to or competes with Cellink AB, Bone Biologics, BICO Group, Anteris Technologies, Brain Scientific, and Tenon Medical. Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patien... More
VentriPoint Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VentriPoint Diagnostics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess VentriPoint Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 39.74 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 9.09 |
VentriPoint Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for VentriPoint Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VentriPoint Diagnostics' standard deviation. In reality, there are many statistical measures that can use VentriPoint Diagnostics historical prices to predict the future VentriPoint Diagnostics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | (2.29) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VentriPoint Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
VentriPoint Diagnostics Backtested Returns
VentriPoint Diagnostics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0815, which indicates the firm had a -0.0815% return per unit of risk over the last 3 months. VentriPoint Diagnostics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VentriPoint Diagnostics' Risk Adjusted Performance of (0.03), coefficient of variation of (2,040), and Variance of 39.75 to confirm the risk estimate we provide. The entity has a beta of 0.14, which indicates not very significant fluctuations relative to the market. As returns on the market increase, VentriPoint Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding VentriPoint Diagnostics is expected to be smaller as well. At this point, VentriPoint Diagnostics has a negative expected return of -0.54%. Please make sure to validate VentriPoint Diagnostics' skewness, as well as the relationship between the rate of daily change and period momentum indicator , to decide if VentriPoint Diagnostics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.48 |
Average predictability
VentriPoint Diagnostics has average predictability. Overlapping area represents the amount of predictability between VentriPoint Diagnostics time series from 23rd of September 2024 to 23rd of October 2024 and 23rd of October 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VentriPoint Diagnostics price movement. The serial correlation of 0.48 indicates that about 48.0% of current VentriPoint Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.48 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
VentriPoint Diagnostics lagged returns against current returns
Autocorrelation, which is VentriPoint Diagnostics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting VentriPoint Diagnostics' otc stock expected returns. We can calculate the autocorrelation of VentriPoint Diagnostics returns to help us make a trade decision. For example, suppose you find that VentriPoint Diagnostics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
VentriPoint Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If VentriPoint Diagnostics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if VentriPoint Diagnostics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in VentriPoint Diagnostics otc stock over time.
Current vs Lagged Prices |
| Timeline |
VentriPoint Diagnostics Lagged Returns
When evaluating VentriPoint Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of VentriPoint Diagnostics otc stock have on its future price. VentriPoint Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, VentriPoint Diagnostics autocorrelation shows the relationship between VentriPoint Diagnostics otc stock current value and its past values and can show if there is a momentum factor associated with investing in VentriPoint Diagnostics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in VentriPoint OTC Stock
VentriPoint Diagnostics financial ratios help investors to determine whether VentriPoint OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VentriPoint with respect to the benefits of owning VentriPoint Diagnostics security.